NASD · Healthcare · Medical Devices · USA
Ceribell Inc is a small cap company (market value between $300 million and $2 billion) in the Medical Devices industry.
Ceribell is a medical technology company that develops the Ceribell System, a portable EEG platform for acute care settings. The system combines disposable wearables and a pocket-sized recorder with AI-powered algorithms to enable rapid seizure detection and continuous neurological monitoring by non-specialized healthcare professionals. Ceribell serves hospitals across the United States.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Ceribell Inc stock.
Not valued: We cannot value this company yet.
We do not publish a value for this company: its filings cover three fiscal years and projecting growth needs four in a row.
17 more funds hold it; the full list is part of the paid plan.
All 140 Medical Devices stocks
61 more in this industry show a wider margin of safety.
We do not publish a verdict on CBLL yet. A discounted cash flow projects five years of revenue, so it needs this company’s own growth history: four consecutive fiscal years of accounts, which give three year-on-year growth rates. Its filings on our archive cover three fiscal years so far; the next annual report should close the gap. We could plug in a generic rate, but that would be a valuation of an average company, not of this one.
We do not publish one (as of the 2026-11-17 close). A discounted cash flow projects five years of revenue, so it needs this company’s own growth history: four consecutive fiscal years of accounts, which give three year-on-year growth rates. Its filings on our archive cover three fiscal years so far; the next annual report should close the gap. We could plug in a generic rate, but that would be a valuation of an average company, not of this one.